| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.23 |
2e-06 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |